AKTS
Aktis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.05
+1.50%Institutional positioning
13F filings over the trailing two quarters
New 124Increased 28Reduced 17Sold out 7
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BIOIMPACT CAPITAL LLC | New Position | 4,835,872 | May 15, 2026 |
| MPM BioImpact LLC | Unchanged | 4,835,872 | Aug 14, 2026 |
| EcoR1 Capital, LLC | Unchanged | 4,824,469 | Aug 14, 2026 |
| ECOR1 CAPITAL, LLC | New Position | 4,824,469 | May 15, 2026 |
| BLUE OWL CAPITAL HOLDINGS LP | New Position | 3,161,348 | May 14, 2026 |
| Blue Owl Capital Holdings LP | Reduced | 3,070,219 | Aug 11, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | New Position | 2,317,044 | May 15, 2026 |
| BlackRock, Inc. | Increased | 2,278,358 | Aug 7, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | New Position | 2,123,812 | May 15, 2026 |
| BLACKROCK, INC. | New Position | 2,112,127 | May 13, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 2,051,447 | Aug 14, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,966,244 | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 1,592,043 | Aug 14, 2026 |
| RTW INVESTMENTS, LP | New Position | 1,592,043 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | New Position | 1,564,196 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings